Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
63,038.28 -423.45 (-0.67%) CMC Crypto 200
1,303.65 -61.48 (-4.51%)
IGM Biosciences, Inc. (IGMS)
| Previous close | 10.03 |
| Open | 10.02 |
| Bid | 9.89 x 400 |
| Ask | 9.98 x 400 |
| Day's range | 9.83 - 10.27 |
| 52-week range | 3.81 - 17.70 |
| Volume | |
| Avg. volume | 297,147 |
| Market cap | 586.53M |
| Beta (5Y monthly) | 0.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.71 |
| Earnings date | 10 May 2024 - 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.22 |
GlobeNewswireIGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, at 2:35 p.m. EDT. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.
ZacksAkoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Akoya (AKYA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksIGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
